Literature DB >> 21366386

Percutaneous liver biopsy: patients' point of view.

Luis Fernández-Salazar1, Benito Velayos, Rocío Aller, Félix Lozano, José A Garrote, José M González.   

Abstract

INTRODUCTION: Hepatic fibrosis can be assessed through serum markers or by the implementation of new non-invasive techniques, such as elastography. We must know patients' opinion on percutaneous liver biopsy (PLB) when it comes to comparing it with other procedures. AIMS: To know the point of view of patients undergoing a PLB with regard to information provided to them, as well as the procedures and biopsy consequences. PATIENTS AND METHODS: A questionnaire was sent by mail to 178 patients who underwent PLB from April 2006 to May 2010. Answers were analyzed. Results are expressed in percentages and compared based on gender and age (younger or older than 47 years of age) (Chi-square test).
RESULTS: Ninety patients of the group answered, 44 females, mean age 47 ± 12 years. The answers revealed that 93% of patients rated the information concerning the reasons for a PLB as adequate (86% women and 100% men). As for the information concerning the objective of the procedure, 88% of patients regarded it as adequate (81% of women vs. 93% of men, p = 0.08). As for the information concerning the risks of a biopsy, 77.7% see it as sufficient. About 12.20% of patients did not receive any information on the physician who asked for the PLB, or who performed it. PLB was considered very painful by 14% of patients, painful by 21%, bothersome by 41.1% and barely bothersome by 23% of patients. Thirty-five percent of patients required analgesia after the puncture. Even though 92% of patients regard PLB as a useful procedure, 46% of them have not received any treatment or a different nutritional regime (55.8%, among those older than 47 years of age, p = 0.03). Eighty percent of patients think that PLB has more benefits than drawbacks, although 87% would have opted for a less aggressive technique as long as it would have provided the same information. But 21% of patients would have also preferred a less aggressive technique, even though it provided fewer details.
CONCLUSIONS: In general, PLB is widely approved by patients and is also regarded as a useful procedure. One out of six patients would rather choose a less-aggressive technique even if it provided less information. PLB does not involve changes in the treatment in around a half of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21366386     DOI: 10.3109/00365521.2011.558112

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.

Authors:  An Tang; François Destrempes; Siavash Kazemirad; Julian Garcia-Duitama; Bich N Nguyen; Guy Cloutier
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

Review 2.  Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Jiulian Gu; Shousheng Liu; Shuixian Du; Qing Zhang; Jianhan Xiao; Quanjiang Dong; Yongning Xin
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

3.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

4.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.

Authors:  An Tang; Ajinkya Desai; Gavin Hamilton; Tanya Wolfson; Anthony Gamst; Jessica Lam; Lisa Clark; Jonathan Hooker; Tanya Chavez; Brandon D Ang; Michael S Middleton; Michael Peterson; Rohit Loomba; Claude B Sirlin
Journal:  Radiology       Date:  2014-09-22       Impact factor: 11.105

5.  Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.

Authors:  Yali Qu; Mou Li; Gavin Hamilton; Yingzhen N Zhang; Bin Song
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

6.  Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.

Authors:  Francesco Paparo; Giovanni Cenderello; Matteo Revelli; Lorenzo Bacigalupo; Mariangela Rutigliani; Daniele Zefiro; Luca Cevasco; Maria Amico; Roberto Bandelloni; Giovanni Cassola; Gian Luca Forni; Gian Andrea Rollandi
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

7.  MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects.

Authors:  Zhi Dong; Yanji Luo; Zhongwei Zhang; Huasong Cai; Yanbing Li; Tao Chan; Ling Wu; Zi-Ping Li; Shi-Ting Feng
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

8.  Role of EUS-guided liver biopsy in benign parenchymal disease (with video).

Authors:  Jason Y Huang
Journal:  Endosc Ultrasound       Date:  2018 Jul-Aug       Impact factor: 5.628

9.  Chinese tree shrews as a primate experimental animal eligible for the study of alcoholic liver disease: characterization and confirmation by MRI.

Authors:  Zhihai Shi; Huijie Xing; Chunli Qi; Meixia Fang; Jiangnan Fu; Xingwang Zhang
Journal:  Exp Anim       Date:  2019-09-26

Review 10.  Liver Fibrosis Quantification by Magnetic Resonance Imaging.

Authors:  Léonie Petitclerc; Guillaume Gilbert; Bich N Nguyen; An Tang
Journal:  Top Magn Reson Imaging       Date:  2017-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.